IMMUNITAS THERAPEUTICS
Immunitas is unlocking human immunology using novel single cell analyses to develop targeted therapeutics for patients with challenging, complex cancers. Translating findings from laboratory research to meaningful clinical advances in humans is a longstanding challenge in the oncology field. Immunitas was founded to directly address this problem and unlock a variety of novel drug targets based on discovery rooted in human biology. They are pursuing this goal with a team of pioneers in these are... as across their scientific founders, management, and investors. At Immunitas, they employ a single cell sequencing platform to dissect the biology of immune cells in human tumors. Their focus on human samples allows us to start with and stay closer to the most relevant and translatable biology for patients and accelerates the pace of their research. They are identifying novel, exciting oncology targets and, importantly, developing key biomarkers to guide the selection of patients who may benefit from their new drugs. They are leveraging expertise in antibody discovery and engineering to create powerful therapies that modulate these targets, and are currently advancing a number of programs toward early human studies.
IMMUNITAS THERAPEUTICS
Industry:
Biotechnology Health Care Life Science Therapeutics
Founded:
2019-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.immunitastx.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
97 M USD
Technology used in webpage:
Euro Microsoft Azure DNS Squarespace Hosted Mimecast
Similar Organizations
Acrivon Therapeutics
Acrivon Therapeutics is a precision oncology therapeutics company specializing in drug development through early clinical treatment success.
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
AuB
AuB is an intestinal microflora analysis that contributes to the athlete's performance improvement and human health maintenance.
Autobahn Therapeutics
Autobahn Therapeutics is a developer of regenerative medicines to restore hope for people affected by CNS disorders.
Hive
Hive Biosystems helps pharmaceutical companies streamline genetics-driven drug discovery by rapidly generating transgenic animals.
Inso Biosciences
Inso Bio is a Cornell University-based early-stage biotech company that develops platform technology for biological sample processing.
Kingdom Supercultures
Kingdom Supercultures create microbial cultures that help food manufacturers to create new foods with boosted benefits.
St. Teresa Medical
St. Teresa Medical is a medical applications developing company commercializing a hemostatic technology platform called FASTCLOT.
Tag.bio
Tag.bio has developed a novel data science platform that allows domain experts to quickly find insights in data.
Vigil Neuroscience
Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.
XinThera
XinThera is a drug discovery company focused on building small molecule oncology and immunology pipeline.
Current Advisors List
Current Employees Featured
Founder
Investors List
M Ventures
M Ventures investment in Series B - Immunitas Therapeutics
Evotec
Evotec investment in Series B - Immunitas Therapeutics
120 Capital Management
120 Capital Management investment in Series B - Immunitas Therapeutics
NS Investment
NS Investment investment in Series B - Immunitas Therapeutics
BrightEdge Fund
BrightEdge Fund investment in Series B - Immunitas Therapeutics
Leaps by Bayer
Leaps by Bayer investment in Series B - Immunitas Therapeutics
Medical Excellence Capital
Medical Excellence Capital investment in Series B - Immunitas Therapeutics
Longwood Fund
Longwood Fund investment in Series B - Immunitas Therapeutics
Ono Venture Investment
Ono Venture Investment investment in Series B - Immunitas Therapeutics
Novartis Venture Fund
Novartis Venture Fund investment in Series B - Immunitas Therapeutics
Key Employee Changes
Official Site Inspections
http://www.immunitastx.com Semrush global rank: 2.96 M Semrush visits lastest month: 5.5 K
- Host name: 198.49.23.145
- IP address: 198.49.23.145
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
